Previous Close | 0.6400 |
Open | 0.6000 |
Bid | 0.5400 |
Ask | 0.5900 |
Strike | 32.00 |
Expire Date | 2024-10-18 |
Day's Range | 0.5800 - 0.6300 |
Contract Range | N/A |
Volume | |
Open Interest | 1.75k |
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Pfizer stock is struggling to retake its 200-day line despite promising updates in cancer treatment. Is PFE stock now a sell?